Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation ...Middle East

PR Newswire - News
Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation
SHANGHAI, Aug. 27, 2022 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (Sanyou) and Shanghai KangaBio Co., Ltd. (KangaBio) have reached an antibody drug licensing agreement, regarding a proprietary monoclonal antibody drug developed by Sanyou, which grants...

Hence then, the article about sanyou biopharmaceuticals and kangabio established strategic collaboration to accelerate antibody drug development and innovation was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation )

Apple Storegoogle play

Last updated :

Also on site :